These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34697424)

  • 1. p21-Activated kinases as promising therapeutic targets in hematological malignancies.
    Wu A; Jiang X
    Leukemia; 2022 Feb; 36(2):315-326. PubMed ID: 34697424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P21 activated kinase signaling in cancer.
    Rane CK; Minden A
    Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.
    Shao YG; Ning K; Li F
    World J Gastroenterol; 2016 Jan; 22(3):1224-35. PubMed ID: 26811660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21-activated kinase inhibitors.
    Rudolph J; Crawford JJ; Hoeflich KP; Chernoff J
    Enzymes; 2013; 34 Pt. B():157-80. PubMed ID: 25034104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell lines.
    Wright GM; Gimbrone NT; Sarcar B; Percy TR; Gordián ER; Kinose F; Sumi NJ; Rix U; Cress WD
    PLoS One; 2021; 16(6):e0252927. PubMed ID: 34138895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.
    Menges CW; Sementino E; Talarchek J; Xu J; Chernoff J; Peterson JR; Testa JR
    Mol Cancer Res; 2012 Sep; 10(9):1178-88. PubMed ID: 22798428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21-Activated Kinases in Thyroid Cancer.
    Bautista L; Knippler CM; Ringel MD
    Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32609833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of p-21-activated kinases in cancer progression.
    King H; Nicholas NS; Wells CM
    Int Rev Cell Mol Biol; 2014; 309():347-87. PubMed ID: 24529727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.
    Licciulli S; Maksimoska J; Zhou C; Troutman S; Kota S; Liu Q; Duron S; Campbell D; Chernoff J; Field J; Marmorstein R; Kissil JL
    J Biol Chem; 2013 Oct; 288(40):29105-14. PubMed ID: 23960073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAK signaling in cancer.
    Ye DZ; Field J
    Cell Logist; 2012 Apr; 2(2):105-116. PubMed ID: 23162742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21-Activated kinase inhibitors: a patent review.
    Crawford JJ; Hoeflich KP; Rudolph J
    Expert Opin Ther Pat; 2012 Mar; 22(3):293-310. PubMed ID: 22404134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho family GTPase signaling through type II p21-activated kinases.
    Chetty AK; Ha BH; Boggon TJ
    Cell Mol Life Sci; 2022 Nov; 79(12):598. PubMed ID: 36401658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pak protein kinases and their role in cancer.
    Dummler B; Ohshiro K; Kumar R; Field J
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):51-63. PubMed ID: 19165420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration.
    Ma Y; McCarty SK; Kapuriya NP; Brendel VJ; Wang C; Zhang X; Jarjoura D; Saji M; Chen CS; Ringel MD
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1314-22. PubMed ID: 23709653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer.
    Yi C; Maksimoska J; Marmorstein R; Kissil JL
    Biochem Pharmacol; 2010 Sep; 80(5):683-9. PubMed ID: 20302846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of p21-activated kinases (PAKs).
    Rudolph J; Crawford JJ; Hoeflich KP; Wang W
    J Med Chem; 2015 Jan; 58(1):111-29. PubMed ID: 25415869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders.
    Zhang K; Wang Y; Fan T; Zeng C; Sun ZS
    Protein Cell; 2022 Jan; 13(1):6-25. PubMed ID: 33306168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading?
    Liu H; Liu K; Dong Z
    Front Cell Dev Biol; 2021; 9():641381. PubMed ID: 33796531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAK as a therapeutic target in gastric cancer.
    Li X; Liu F; Li F
    Expert Opin Ther Targets; 2010 Apr; 14(4):419-33. PubMed ID: 20146633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P21 activated kinases: structure, regulation, and functions.
    Rane CK; Minden A
    Small GTPases; 2014; 5():. PubMed ID: 24658305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.